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Abstract
There are concerns about the health effects of formaldehyde exposure, including carcinogenicity,
in light of elevated indoor air levels in new homes and occupational exposures experienced by
workers in health care, embalming, manufacturing and other industries. Epidemiological studies
suggest that formaldehyde exposure is associated with an increased risk of leukemia. However, the
biological plausibility of these findings has been questioned because limited information is
available on formaldehyde’s ability to disrupt hematopoietic function. Our objective was to
determine if formaldehyde exposure disrupts hematopoietic function and produces leukemia-
related chromosome changes in exposed humans. We examined the ability of formaldehyde to
disrupt hematopoiesis in a study of 94 workers in China (43 exposed to formaldehyde and 51
frequency-matched controls) by measuring complete blood counts and peripheral stem/progenitor
cell colony formation. Further, myeloid progenitor cells, the target for leukemogenesis, were
cultured from the workers to quantify the level of leukemia-specific chromosome changes,
including monosomy 7 and trisomy 8, in metaphase spreads of these cells. Among exposed
workers, peripheral blood cell counts were significantly lowered in a manner consistent with toxic
effects on the bone marrow and leukemia-specific chromosome changes were significantly
elevated in myeloid blood progenitor cells. These findings suggest that formaldehyde exposure
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can have an adverse impact on the hematopoietic system and that leukemia induction by
formaldehyde is biologically plausible, which heightens concerns about its leukemogenic potential
from occupational and environmental exposures.
INTRODUCTION
Formaldehyde and goods containing this chemical reportedly account for more than 5% of
the yearly US Gross National Product (GNP), which is about $500 billion. There are
longstanding concerns about the adverse health effects of formaldehyde exposure, including
carcinogenicity, for professionals exposed to formalin-based fixatives such as pathologists,
anatomy students, nurses and embalmers, and for workers exposed to formaldehyde in
manufacturing. Recently, public awareness of this issue has been raised in the wake of
Hurricane Katrina, as high levels of formaldehyde have been found in the temporary
housing trailers provided by the Federal Emergency Management Agency (FEMA). At the
same time, a large number of workers are exposed to formaldehyde in their workplaces (1).
A significantly greater number of people are exposed to lower levels of formaldehyde in the
environment, as it is generated by automobile engines (2), is present in tobacco smoke, and
is released from various household products such as plywood, particleboard, furniture and
carpeting (3–5).
Recently, the International Agency for Research on Cancer (IARC) classified formaldehyde
as a known human carcinogen (Group 1) based on “sufficient epidemiological evidence that
formaldehyde causes nasopharyngeal cancer in humans” (3,5). IARC also concluded that
there was “strong but not sufficient evidence for a causal association between leukemia and
occupational exposure to formaldehyde” (3,5). The known impact of formaldehyde on the
human cancer burden would increase markedly if it was found to cause leukemia in addition
to nasopharyngeal cancer, which is relatively rare (6). The evidence for an association with
leukemia came primarily from a number of epidemiological studies. Several studies of
pathologists, embalmers and other professionals exposed to formaldehyde (7–12) have
observed an increased risk of leukemia, with myeloid leukemia being most prominent in
some studies, as well as modest associations with lymphoma. Further, two major industrial
cohort studies of formaldehyde-exposed workers have also shown elevated risks of lympho-
hematopoietic cancers, especially myeloid leukemia (13,14). The most recent update of one
of these studies with an additional 10 years of follow-up continues to suggest a possible link
between formaldehyde exposure and mortality due to lymphohematopoetic malignancies,
particularly myeloid leukemia (15). However, results from a British cohort study did not
show the same association (16).
Although the epidemiological data are generally consistent with a causal association
between leukemia and occupational exposure to formaldehyde and chromosome damage has
been observed in the blood cells of exposed workers (17–21), questions have been raised
over whether or not formaldehyde reaches the bone marrow, due to its highly reactive
nature, and whether it damages hematopoietic stem or progenitor cells, which are the targets
for leukemogenesis (22–26). One of the clinical consequences of damage to hematopoietic
stem or progenitor cells is a decrease in circulating red blood cell, white blood cell and
platelet counts. Human leukemogens cause a marked decrease in white blood cell, platelet
and red blood cell counts at high doses and lower the ability of progenitor cells to replicate
in colony-forming cell culture assays (27,28). For example, the number of granulocyte-
macrophage colonies in culture (CFU-GM) is used as an indicator of stem cell changes
caused by ionizing radiation and cancer chemotherapy (29,30). Thus, if formaldehyde were
a human leukemogen, one would expect to see a lowering of peripheral blood counts in
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exposed workers and an effect on the ability of progenitor cells to form granulocyte-
macrophage colonies in culture (CFU-GM).
The published data on formaldehyde hematotoxicity are limited and inconsistent. Several
previous studies have shown that formaldehyde alters the counts of different types of blood
cells. One study reported that exposure to formaldehyde in humans reduced white blood cell
counts (31). Another recent study concluded that formaldehyde increased B cells, but
decreased total T cells (CD3) and T-suppressor cells (CD8) in the blood of exposed workers,
while T-helper cells (CD4) cells remained unchanged (19). However, a study of people
environmentally exposed to formaldehyde during an accidental spill showed no difference in
white blood cells, lymphocytes, or T-cells (CD4 and CD8) (32). In male rats exposed to a
high dose of formaldehyde, increased monocytes, red blood cells and hemoglobin were
detected, but lymphocyte counts were decreased (33).
On the other hand, several studies in experimental animals have shown increased levels of
cytogenetic damage in the bone marrow of formaldehyde-exposed mice and rats (17,34),
and in Syrian hamster embryo cells exposed to formaldehyde in vitro (35). Formaldehyde
clearly damages chromosomes and may potentially cause the specific cytogenetic changes
found in hematological malignancies if it reaches the target cells of importance. Early blood
stem and progenitor cells are the target cells involved in leukemogenesis (36). Mutations
arising in these cells through gene mutation or chromosome breaks and aneuploidy may give
rise to leukemic stem cells (37). To date, however, formaldehyde has not been reported to
induce leukemia-specific chromosomal alterations in human blood stem or progenitor cells.
In the present study we have examined this issue both in exposed humans and in cell
cultures to evaluate the capacity of formaldehyde to produce hematotoxicity and cause
damage to hematopoietic progenitor cells. To achieve this goal a molecular epidemiology
study of workplaces in Guangdong, China was performed in which we measured the
complete blood counts (CBC), CFU-GM and leukemia-specific chromosome changes
among formaldehyde-exposed and unexposed workers.
MATERIALS AND METHODS
Identification of study factories
We identified one factory that produced formaldehyde-melamine resins and one factory that
used formaldehyde-melamine resins to manufacture plastic utensils. Monitoring of
formaldehyde levels was performed in these factories during an initial screening and it was
established that there were no other exposures to known or suspected leukemogens or
hematotoxicants (e.g., benzene, phenol, chlorinated solvents). We selected a control
population from three workplaces in the same geographic region as factories with
formaldehyde exposure and enrolled workers who had comparable demographic and
socioeconomic characteristics and who were engaged primarily in manufacturing. Detailed
inspection of the control workplaces did not identify potential for occupational exposure to
formaldehyde or any other hematotoxic or genotoxic chemicals in excess of exposure levels
in the general population.
Characteristics of study subjects
The study was approved by Institutional Review Boards at the U.S. National Cancer
Institute and the Guangdong Poisoning Control Center, participation was voluntary, and
written informed consent was obtained. All exposed workers had to meet two inclusion
criteria: 1) they had to have had formaldehyde exposure levels of about 1 to 2 ppm on most
days during the initial screening; and 2) they held the same job for at least the previous 3
months in the same factory. Exclusion criteria for both formaldehyde-exposed and control
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workers were history of cancer, chemotherapy, and radiotherapy, as well as previous
occupations with notable exposure to benzene, butadiene, styrene and/or ionizing radiation.
We enrolled 43 study subjects exposed to relatively high levels of formaldehyde (mostly
between 0.6 and 2.5 ppm). Forty-one of the 43 workers (95%) worked in the study factories
for at least one year. We enrolled 51 controls who were frequency-matched by age (±5
years) and gender to the exposed workers. The participation rates for formaldehyde-exposed
workers and controls were 92% and 95%, respectively. Subjects were administered a
questionnaire by trained interviewers requesting information on occupational history,
environmental exposures, medical history and current medications, and past and current
tobacco and alcohol use (Table 1) on the same day that biologic samples were collected.
Exposure assessment
Formaldehyde exposure was monitored with UMEx 100 diffusion samplers. Samplers were
worn by the workers in the exposed workplaces for a full-shift (> 240 min) on ~3 working
days over a three-week period. Study subjects were interviewed and biologic samples were
collected towards the end of this period. Each formaldehyde-exposed subject had a
minimum of two diffusion samplers collected. The average formaldehyde exposure level
was calculated by taking the arithmetic mean of each subject’s measurements. A subgroup
of workers in the unexposed workplaces was monitored for formaldehyde exposure on a
single day. The limit of detection was 0.012 ppm. Personal exposure to other organic
compounds was measured at least twice for each formaldehyde-exposed worker by 3MTM
organic vapor monitors (OVM). OVMs were analyzed for chloroform, methylene chloride,
tetrachloroethylene, trichloroethylene, and benzene, and no hydrocarbons were detected in
any of the selected samples. The analysis laboratory was blinded with regard to the source of
the diffusion samplers. Urinary benzene was measured in a subset of enrolled subjects (20
controls and 21 workers from both exposed factories) using GC-MS methods as described
by Kim et al. (38). Although it was an original exclusion criteria, the potential for exposure
to benzene, radiation and other potential hematotoxic agents in previous jobs was assessed
systematically by review of each worker’s detailed occupational history.
Biological sampling
In June and July 2006, we obtained biological samples from the 94 study subjects at their
workplaces after informed consent was obtained. Biological samples were collected after the
formaldehyde-exposed workers had been monitored at least twice for personal formaldehyde
air exposure in their workplace. Chinese physicians from the Guangdong Poisoning Control
Center conducted a standard physical examination that included evaluation for signs of
current upper or lower respiratory infection and measurements of temperature, blood
pressure, height and weight, CBC with differential, and lymphocyte subsets, as well as
routine biochemical tests (standard liver and renal chemistries) in blood and urine.
Peripheral blood and urine samples (post-shift and overnight) were collected from each
study subject and delivered to the processing laboratories within ~4h of collection. Blood
from each study subject was drawn into different vacutainer tubes by specially trained
nurses. This was used for the culture of peripheral blood myeloid progenitor cells (CFU-
GM) using a methylcellulose based colony assay (described in detail below), whole blood
cultures to prepare metaphase spreads, and the measurement of the CBC and differential
(which was analyzed using a Sysmex XT-1800i automated hematology analyzer (Kobe,
Japan) with coefficients of variation< 5% for all endpoints). Field collection and laboratory
processing personnel differed and the biological samples were coded so that laboratory
personnel on-site were blinded with respect to exposure status.
A portion of each type of biological sample, including prepared slides, was shipped to
Bioreliance Inc. (Rockville, MD) under contract to NCI, where the samples were recoded
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and sent to the U.C. Berkeley laboratory for analysis. Thus, all laboratory analyses carried
out after completion of the field phase of the study were performed blinded to exposure
status.
Culturing of Myeloid Progenitor Cells
It is extremely difficult to obtain bone marrow from around 100 healthy workers under field
conditions in occupational studies to directly evaluate the effect of formaldehyde exposure
on bone marrow cells. However, a fraction of hematopoietic stem and progenitor cells
circulate in the bloodstream in dynamic equilibrium with the stem cell pools in the bone
marrow. These cells can be cultured in colony-forming assays to measure their proliferative
potential in semi-solid media containing appropriate growth factors (28). The individual
colonies can be classified microscopically according to the progenitor cell type. Colonies
arising from the most primitive, early progenitor cells are called colony-forming-unit–
granulocyte, erythroid, macrophage, megakaryocyte (CFU-GEMM) because the progenitors
can give rise to any of these mature cells. Colonies derived from more committed progenitor
cells that give rise to reticulocytes and erythrocytes are called burst-forming unit–erythroid
(BFU-E), whereas those that give rise to granulocytes and macrophages are called colony-
forming unit–granulocyte-macrophage (CFU-GM).
We applied the CFU-GM colony-forming assay to peripheral blood mononuclear cells from
43 exposed workers and 51 frequency-matched controls. Hematopoietic progenitor cells
from the peripheral blood were cultured in growth factor-containing methylcellulose media
(MethoCult GF H4534, according to the protocol provided by StemCell Technologies Inc)
without erythropoietin (EPO) and the number of CFU-GM colonies formed was scored in 6
petri dishes after 14 days. Limitations of the field setting and personnel available only
allowed for cultures without EPO to be prepared, therefore only CFU-GM colonies could be
examined in vivo and not BFU-E or CFU-GEMM.
For laboratory studies performed in vitro, formaldehyde-treated mononuclear cells from a
volunteer of Chinese origin were cultured in the same media in the absence or presence of
EPO, such that colonies of BFU-E, CFU-GM and CFU-GEMM were formed after 14 days
of culture. Formaldehyde, diluted from a 37% solution, was added on day 1 to final
concentrations of 0, 100, 150 and 200 μM, which is in the dose-range found in human blood
(39,40) and utilized in many in vitro studies including in cultured human blood cells (41,42).
A young male volunteer was used as the blood donor for these cell culture experiments to
reduce variation.
Metaphase Preparation from Cultured CFU-GM Cells
Metaphases from CFU-GM cells were prepared after 14 days of culture by adding colcemid
(0.05 μg/ml) to 6 petri dishes overnight prior to harvest. CFU-GM colony cells were
harvested, washed, and dispersed into a hypotonic solution (0.075 M KCI). After 30 min, the
cells were fixed in methanol-acetic acid (3:1) twice and then dropped onto several slides, air
dried, and stored in slide boxes at −20°C.
Fluorescence in situ Hybridization (FISH)
The loss of chromosome 7 and gain of chromosome 8 are among the most frequent
cytogenetic changes observed in myeloid leukemia and myelodysplastic syndromes (43) and
can be readily analyzed by FISH. These leukemia-specific chromosome changes in CFU-
GM cells were examined in a subset of study subjects selected from the most highly exposed
workers (n = 10) and in 12 unexposed controls frequency-matched to the 10 exposed
workers by age and sex (characteristics of the two groups and exposure levels shown in
Table 2). Specifically, the loss (monosomy) of chromosome 7 and gain (trisomy) of
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chromosome 8 was examined using FISH staining of metaphase spreads as previously
described (44–46). Briefly, fixed metaphase spreads were prepared from cultured CFU-GM
progenitor cells of exposed or control workers. Chromosomes 7 and 8 were painted with
FISH probes directly labeled with FITC (green) and Texas Red (red). The probes and target
DNA were simultaneously denatured, washed rapidly using a formamide-free stringency
wash-solution, and each metaphase spread was evaluated microscopically. For efficiency, all
scorable metaphase spreads on each slide were analyzed, and a minimum of 150 cells per
subject were scored.
Statistical Analysis
Unadjusted summary measures are presented for all endpoints. Linear regression using the
natural logarithm (ln) of data derived from the CBC was used to test for differences between
workers exposed to formaldehyde and controls. Negative binomial regression was used to
analyze CFU-GM, monosomy 7, and trisomy 8 data. All analyses were carried out using
SAS version 8.0 software (SAS Institute, Cary, North Carolina, USA). The frequency-
matching variables, age and sex were included in all models. Additional covariates that have
been variably reported to influence these endpoints were included in the final models (i.e.,
current cigarette smoking status (yes/no), current alcohol consumption (yes/no), recent
infections (flu or respiratory infections in the previous month), and BMI (Body Mass
Index)) if they were significant at p < 0.05 or if there was evidence of confounding (i.e.,
greater than a 15% change in the regression coefficient). Smoking was the only covariate, in




Exposed subjects were young (mean±SD: 31±6 years), male (86%), and similar to the
unexposed controls (Table 1). The median (10th, 90th percentile) formaldehyde exposure
level in the formaldehyde-melamine resin producing factory was 1.13 (0.94, 1.38) ppm and
in the utensil factory 1.32 (0.51, 2.60) ppm, respectively. For all 43 exposed subjects the
median was 1.28 (0.63, 2.51) ppm as an 8 h time-weighted average (Table 1).
Blood cell counts in formaldehyde-exposed and unexposed workers
Total white blood cell (WBC) counts were significantly lower in workers exposed to
formaldehyde compared to controls [mean (SD): 5,422 (1,529) cells per μl blood vs. 6,269
(1,422), respectively, p = 0.0016, Figure 1]. Lower levels were also observed for all the
major myeloid cell types, including granulocytes, platelets, and red blood cells (RBC), and
the mean corpuscular volume (MCV) of RBC was elevated (Figure 1). In addition, the
lymphocyte count was significantly lower (p = 0.0002) in workers exposed to formaldehyde
compared with controls (Figure 1). The observed effects were unlikely due to the presence
of other hematotoxic agents, such as benzene, because lowered blood counts were found at
both workplaces that used formaldehyde, and no co-exposures with known hematotoxic or
genotoxic properties were detected. We also measured urinary benzene in a subset of
workers exposed to formaldehyde (n = 21) and unexposed subjects (n = 20) and found
essentially the same low background levels in both groups (mean±SD, 0.027±0.035 μg/L in
exposed workers and 0.042±0.087 μg/L in controls). Detailed review of previous
occupations identified 10 workers (4 exposed to formaldehyde, 6 controls) who had the
potential for previous exposure to solvents. Adjusting for these potential past exposures, or
excluding these subjects from the analysis, had a negligible impact on the results (data not
shown).
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Colony formation from myeloid progenitor cells of formaldehyde-exposed and unexposed
workers
As formaldehyde exposure was associated with abnormalities in the myeloid, erythroid and
lymphoid lineages of exposed workers, it seemed likely that formaldehyde produced an
inhibitory effect on stem or progenitor cell differentiation in the bone marrow. Since a
fraction of hematopoietic stem and progenitor cells circulate in the bloodstream in dynamic
equilibrium with the stem cell pools in the bone marrow, we were able to examine this
possibility by measuring colony formation from circulating CFU-GM progenitor cells using
peripheral blood from the study subjects. A 20% decrease in colony formation from
progenitor cells was observed in the formaldehyde-exposed workers (which is slightly
greater than the 14% reduction observed in peripheral white blood cell counts), but this was
not statistically significant (p = 0.10; Figure 2). This suggests a possible toxic and/or
inhibitory effect of formaldehyde on the myeloid progenitor cells in the exposed workers.
Effect of formaldehyde on human myeloid progenitor cells in vitro
We expanded upon the studies in exposed workers by performing cell culture studies to
investigate the impact of formaldehyde on human blood progenitor cells in culture.
Hematopoietic myeloid progenitor cells were cultured in the absence and presence of EPO,
so that CFU-GM, BFU-E and CFU-GEMM colonies were formed. Figure 3 shows that the
colony forming number of all progenitor cell types was significantly decreased with
increasing concentrations of formaldehyde, with the most primitive CFU-GEMM
progenitors showing a linear negative dose-response relationship. These in vitro data (Figure
3) are consistent with the decreased CFU-GM colony formation found in workers exposed to
formaldehyde (Figure 2) and suggest that formaldehyde inhibits the proliferation of myeloid
progenitor cells.
Detection of leukemia-specific chromosome aneuploidy in the progenitor cells of
formaldehyde-exposed and unexposed workers
In a subset of highly exposed subjects (n=10) and matched controls (n=12) (Table 2), we
examined aneuploidy of chromosomes 7 and 8 in metaphase spreads prepared from the
cultured CFU-GM colony cells. The frequency of monosomy (loss) of chromosome 7 in
formaldehyde-exposed workers was significantly elevated (p = 0.0039) compared with their
matched controls, while the frequency of trisomy 8 (gain) had a 4-fold significant increase
(p = 0.040) (Figure 4). Formaldehyde exposure was, therefore, associated with an increase in
leukemia-specific chromosomal aneuploidy in the hematopoietic progenitor cells of the
exposed workers. Three of these study subjects (1 exposed to formaldehyde, 2 controls) had
the potential for previous exposure to solvents. Adjusting for these potential past exposures
or excluding these subjects from the analysis had a negligible impact on the results (data not
shown).
DISCUSSION
The findings described here add biologic support to traditional epidemiological studies that
have shown an association between formaldehyde exposure and increased risk of myeloid
leukemia (8,10,13,14). In the present study, we found that formaldehyde-exposed workers
had lower blood counts in vivo consistent with toxic effects on the bone marrow and that
formaldehyde exposure in vitro affected human hematopoietic stem or myeloid progenitor
cells at toxicologically relevant concentrations. We also showed in a subset of the most
highly exposed subjects that monosomy (loss) of chromosome 7 and trisomy (gain) of 8
were significantly elevated in the myeloid progenitor cells of formaldehyde-exposed
workers compared with unexposed controls. We examined the loss of chromosome 7 and
gain of chromosome 8 because they are among the most frequent cytogenetic changes
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observed in myeloid leukemia and myelodysplastic syndromes (43) and have been shown to
be affected by exposure to the established human leukemogen, benzene (44,46). Thus,
formaldehyde exposure was associated with increased levels of specific chromosome
aberrations related to myeloid leukemia in the stem/progenitor cells that are the targets for
leukemogenesis. Future studies should aim to replicate these findings, and examine
additional chromosomes, such as chromosome 5 which is also commonly altered in myeloid
leukemias (47,48), and to detect leukemia-related structural changes such as translocations
and deletions.
Only a few previous studies of hematological parameters have been reported in
formaldehyde-exposed humans in the English literature. A study of nurses in Taiwan
showed that exposure to formaldehyde was correlated with reduced white blood cell counts
(31). A recent study in China showed that formaldehyde was associated with lowered T-
lymphocytes in the blood of exposed workers, but data on myeloid cells was not provided
(19). Several studies in the Chinese literature also reported that occupational formaldehyde
exposure was associated with a decrease in white blood cell counts and possibly other cell
counts such as platelets (49), which is consistent with our findings.
Particular strengths of the hematological evaluation in our study include a comprehensive
evaluation of formaldehyde’s possible effects on hematological parameters, assessment of
potential confounding factors, and extensive exposure assessment. Our sample size was
relatively small, but large enough to observe statistically significant associations. With an
average exposure of 1.28 ppm as an 8 h time-weighted average, which is somewhat higher
than the US Permissible Exposure Limit of 0.75 ppm, the subjects in our study were highly
exposed and may explain why we were able to see hematotoxic effects in a relatively small
population. Additional studies are needed to replicate these findings, preferably with a larger
sample size and a broader range of exposures including relatively lower exposed individuals.
Future studies could perhaps also be enhanced by using biomarkers of cumulative internal
dose. However, no such biomarkers exist at present although some are in development and
show promise. These include formaldehyde-DNA adducts (50) and adducts between
glutathione and DNA induced by formaldehyde (51).
Our study is also unique in that we studied the effect of formaldehyde exposure both in vivo
and in vitro on colony formation from the hematopoietic progenitor cells that circulate in the
bloodstream in dynamic equilibrium with those in the bone marrow. A 20% decrease in
colony formation from CFU-GM progenitor cells was observed in the exposed workers,
which approached statistical significance. We were able to show that CFU-GM progenitor
cells are sensitive to formaldehyde exposure in cell culture at toxicologically relevant
concentrations, and the more primitive CFU-GEMM progenitors, that give rise to all
myeloid cells, showed a linear negative dose-response relationship. These effects were
observed at concentrations between 100 and 200 μM, which are toxicologically relevant
because background levels of formaldehyde in human blood have been reported to be 50–
100 μM (39,40). Since CFU-GEMM multipotential myeloid progenitor cells and the earlier
pluripotential stem cells are the target cells for leukemogenesis and are converted to
leukemic stem cells in acute myeloid leukemia, the finding that formaldehyde damages these
cells adds weight to the notion that it may be associated with myeloid leukemia.
It seems unlikely that the effects we observed on hematological parameters and
chromosomal changes were due to confounding factors, such as the presence of other
hematotoxic agents apart from formaldehyde, because lowered blood counts were found at
both workplaces that used formaldehyde, and no co-exposures with known hematotoxic or
genotoxic properties were detected. Further, adjustment for potential exposure to
hematotoxicants in previous occupations had no impact on the results and the control
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population from 3 different factories had no occupational exposure to formaldehyde or any
other hematotoxic or genotoxic chemicals in excess of levels in the general population. It is
theoretically possible that other confounding factors, such as a lower dietary vitamin B12,
could explain the elevated MCV and lowered blood counts in the exposed workers
compared to their matched controls. However, all the workplaces studied were in the same
geographic region and the enrolled workers had comparable demographic and
socioeconomic characteristics and were engaged primarily in manufacturing. Thus,
significantly different dietary, genetic and environmental factors, other than formaldehyde
are unlikely to explain the results.
Given the fact that formaldehyde is a highly reactive gas, the question arises as to how it
reaches the blood and bone marrow to elicit toxic effects. Several studies have reported
increased chromosomal damage in the form of aberrations and micronuclei in circulating
peripheral blood lymphocytes of workers exposed to formaldehyde (17–21). Increased levels
of cytogenetic damage have also been reported in the bone marrow of exposed mice and
rats, suggesting that formaldehyde reaches the bone marrow in experimental animals
(17,34). In aqueous solution, formaldehyde is converted mostly to oligomers of its diol form,
methanediol (formaldehyde hydrate, CH2(OH)2, or methylene glycol), and a dynamic
equilibrium with formaldehyde is formed. The concentration of the diol oligomers versus
that of formaldehyde depends on the precise conditions (temperature, pH, formaldehyde
concentration) under which the reaction occurs (52). Thus, methanediol, with a molecular
weight of only 48, which can readily penetrate into tissues, may travel to the marrow
through the blood where it is in equilibrium with reactive formaldehyde. The formaldehyde,
once generated, can react with cellular macromolecules producing toxic injury (53).
It is possible, therefore, that formaldehyde promotes leukemogenesis through direct
induction of DNA damage and chromosome aneuploidy in hematopoietic stem or early
progenitor cells in the bone marrow. This hypothesis clearly requires additional testing and
there are at least two alternate mechanisms. As suggested by Zhang et al formaldehyde may
induce leukemia by damaging hematopoietic stem/progenitor cells circulating in the
peripheral blood; or by damaging the primitive pluripotent stem cells present within the
nasal turbinates and/or olfactory mucosa (54). In either of these two alternate models,
damaged stem/progenitor cells would then travel to the bone marrow and become initiated
leukemic stem cells (54). However, the data described herein and the earlier findings of
cytogenetic damage in the blood and marrow of humans and mice suggests that
formaldehyde damages hematopoietic stem or early progenitor cells in the bone marrow
and/or peripheral blood. Overall, the data presented here heighten concern about the
leukemogenic potential of formaldehyde and suggest that the carcinogenic risk presented by
this ubiquitous compound should be evaluated further.
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Fig. 1. Myeloid, erythroid and lymphocyte blood cell counts in formaldehyde-exposed and
unexposed workers
A total of 43 workers exposed to formaldehyde and 51 controls were studied. Differences in
cell counts were tested by linear regression, adjusting for relevant covariates as indicated in
Methods. The p values are indicated as: * p < 0.05; ** p < 0.01; and *** p < 0.001. (WBC,
white blood cells; RBC, red blood cells; Hgb, hemoglobin in g/deciliter; and, MCV, mean
corpuscular volume in femtoliters as fl).
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Fig. 2. Colony formation from the colony-forming unit–granulocyte/macrophage (CFU- GM)
hematopoietic progenitors in formaldehyde-exposed and unexposed workers
Hematopoietic progenitor cells from the peripheral blood of 43 exposed workers and 51
frequency-matched controls were cultured in methylcellulose-based media without
erythropoietin. Differences in cell counts were tested by negative binomial regression,
adjusting for relevant covariates as indicated in Methods. The lower and higher edges of box
are the 25 and 75 percentiles of the data, respectively. The lower and higher whiskers are 10
and 90 percentiles, respectively. The central line in the box presents the median and the
cross is the mean. One outlier is indicated as a circle in the exposed group.
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Fig. 3. Colony formation from human myeloid progenitor cells following formaldehyde exposure
in cell culture
Hematopoietic myeloid progenitor cells were cultured from the peripheral blood of a
volunteer of Chinese origin in methylcellulose-based media in the absence and presence of
erythropoietin (EPO), after treatment with formaldehyde. The number of BFU-E (filled
circles,–●–), CFU-GM (squares, –■–) and CFU-GEMM (triangles, –▲–) colonies were
scored in 6 petri dishes after 14 days of culture. CFU-GM colony counts in the absence of
EPO are presented for consistency with the in vivo data. The results shown are the means
and standard errors of 6 separate experiments. The p values are indicated as p trend calculated
using negative binomial regression and robust standard errors adjusting for possible residual
correlation due to being on the same dish using a sandwich-type estimate (GEE approach).
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Fig. 4. Levels of monosomy of chromosome 7 and trisomy of chromosome 8 in the hematopoietic
progenitor cells of formaldehyde-exposed and unexposed workers
Leukemia-specific chromosome changes in CFU-GM cells, such as loss (monosomy) of
chromosome 7 and gain (trisomy) of chromosome 8, were examined in metaphase spreads
of 10 formaldehyde-exposed workers and 12 unexposed matched controls. The data
represent the percentage of the metaphases in which each abnormality is found. Rates of
monosomy are considerably higher in the controls than trisomy because of artifactual
chromosome loss during metaphase spread preparation. Differences in aneuploidy were
tested by negative binomial regression, adjusting for relevant covariates as indicated in
Methods. The p values are indicated as: * p < 0.05 and ** p < 0.01.
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